Published by
@ShahidNShah
@ShahidNShah
FDA & MHRA Revoke COVID-19 Authorisations for Hydroxychloroquine
The U.S. Food and Drug Administration has revoked its emergency use authorisation for chloroquine and hydroxychloroquine as treatments for COVID-19. The U.K. Medicines and Healthcare products Regulatory Agency has followed suit, but Brazil criticised the decision and expanded the drugs’ use.
Continue reading at healthmanagement.org
Make faster decisions with community advice
- Unlock hidden revenue stream: Get top dollar for used equipment
- How one physician practice was transformed by EHR-embedded telehealth
- Ransomware attack leaves 5 years of patient records inaccessible at Colo. hospital
- AI's growing role in treating diabetes, chronic conditions
- Privacy & security perspectives: interoperability, prospects for HIPAA refresh, more
Next Article
-
Unlock hidden revenue stream: Get top dollar for used equipment
Falling inpatient volumes, decreasing Medicare and Medicaid reimbursements, and rising wage inflation are putting pressure on health systems’ top and bottom lines. In response to an increasingly …
Posted Jun 19, 2020medicaid
